skip to main content

Chemistry, part 2

زبان محتوا

پشتیبانی: CRM@email.irandoc.ac.ir

Concept information

organooxygen compound > polyketide > macrolide > milbemycin > (1r,4s,4's,5's,6r,6's,8r,10e,13r,14e,16z,20r,21r,24s)-4',21,24-trihydroxy-5',11,13,22-tetramethyl-6'-[(e)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,18-dione
... > organooxygen compound > ester > carboxylic ester > lactone > macrocyclic lactone > macrolide > milbemycin > (1r,4s,4's,5's,6r,6's,8r,10e,13r,14e,16z,20r,21r,24s)-4',21,24-trihydroxy-5',11,13,22-tetramethyl-6'-[(e)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,18-dione
... > organooxygen compound > carbonyl compound > carboxylic ester > lactone > macrocyclic lactone > macrolide > milbemycin > (1r,4s,4's,5's,6r,6's,8r,10e,13r,14e,16z,20r,21r,24s)-4',21,24-trihydroxy-5',11,13,22-tetramethyl-6'-[(e)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,18-dione
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic oxo compound > carbonyl compound > carboxylic ester > lactone > macrocyclic lactone > macrolide > milbemycin > (1r,4s,4's,5's,6r,6's,8r,10e,13r,14e,16z,20r,21r,24s)-4',21,24-trihydroxy-5',11,13,22-tetramethyl-6'-[(e)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,18-dione
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic oxo compound > carbonyl compound > carboxylic ester > lactone > macrocyclic lactone > macrolide > milbemycin > (1r,4s,4's,5's,6r,6's,8r,10e,13r,14e,16z,20r,21r,24s)-4',21,24-trihydroxy-5',11,13,22-tetramethyl-6'-[(e)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,18-dione
... > organooxygen compound > ester > lactone > macrocyclic lactone > macrolide > milbemycin > (1r,4s,4's,5's,6r,6's,8r,10e,13r,14e,16z,20r,21r,24s)-4',21,24-trihydroxy-5',11,13,22-tetramethyl-6'-[(e)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,18-dione
... > organooxygen compound > oxacycle > lactone > macrocyclic lactone > macrolide > milbemycin > (1r,4s,4's,5's,6r,6's,8r,10e,13r,14e,16z,20r,21r,24s)-4',21,24-trihydroxy-5',11,13,22-tetramethyl-6'-[(e)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,18-dione
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > oxacycle > lactone > macrocyclic lactone > macrolide > milbemycin > (1r,4s,4's,5's,6r,6's,8r,10e,13r,14e,16z,20r,21r,24s)-4',21,24-trihydroxy-5',11,13,22-tetramethyl-6'-[(e)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,18-dione
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > lactone > macrocyclic lactone > macrolide > milbemycin > (1r,4s,4's,5's,6r,6's,8r,10e,13r,14e,16z,20r,21r,24s)-4',21,24-trihydroxy-5',11,13,22-tetramethyl-6'-[(e)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,18-dione
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > lactone > macrocyclic lactone > macrolide > milbemycin > (1r,4s,4's,5's,6r,6's,8r,10e,13r,14e,16z,20r,21r,24s)-4',21,24-trihydroxy-5',11,13,22-tetramethyl-6'-[(e)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,18-dione
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > macrocycle > macrocyclic lactone > macrolide > milbemycin > (1r,4s,4's,5's,6r,6's,8r,10e,13r,14e,16z,20r,21r,24s)-4',21,24-trihydroxy-5',11,13,22-tetramethyl-6'-[(e)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,18-dione
... > organooxygen compound > oxacycle > cyclic ketal > spiroketal > milbemycin > (1r,4s,4's,5's,6r,6's,8r,10e,13r,14e,16z,20r,21r,24s)-4',21,24-trihydroxy-5',11,13,22-tetramethyl-6'-[(e)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,18-dione
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > oxacycle > cyclic ketal > spiroketal > milbemycin > (1r,4s,4's,5's,6r,6's,8r,10e,13r,14e,16z,20r,21r,24s)-4',21,24-trihydroxy-5',11,13,22-tetramethyl-6'-[(e)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,18-dione
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > cyclic ketal > spiroketal > milbemycin > (1r,4s,4's,5's,6r,6's,8r,10e,13r,14e,16z,20r,21r,24s)-4',21,24-trihydroxy-5',11,13,22-tetramethyl-6'-[(e)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,18-dione
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > cyclic ketal > spiroketal > milbemycin > (1r,4s,4's,5's,6r,6's,8r,10e,13r,14e,16z,20r,21r,24s)-4',21,24-trihydroxy-5',11,13,22-tetramethyl-6'-[(e)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,18-dione
... > organooxygen compound > acetal > ketal > cyclic ketal > spiroketal > milbemycin > (1r,4s,4's,5's,6r,6's,8r,10e,13r,14e,16z,20r,21r,24s)-4',21,24-trihydroxy-5',11,13,22-tetramethyl-6'-[(e)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,18-dione
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > polycyclic compound > spiro compound > oxaspiro compound > spiroketal > milbemycin > (1r,4s,4's,5's,6r,6's,8r,10e,13r,14e,16z,20r,21r,24s)-4',21,24-trihydroxy-5',11,13,22-tetramethyl-6'-[(e)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,18-dione
... > organooxygen compound > polyketide > macrolide > avermectin analogue > milbemycin > (1r,4s,4's,5's,6r,6's,8r,10e,13r,14e,16z,20r,21r,24s)-4',21,24-trihydroxy-5',11,13,22-tetramethyl-6'-[(e)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,18-dione
... > organooxygen compound > ester > carboxylic ester > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > (1r,4s,4's,5's,6r,6's,8r,10e,13r,14e,16z,20r,21r,24s)-4',21,24-trihydroxy-5',11,13,22-tetramethyl-6'-[(e)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,18-dione
... > organooxygen compound > carbonyl compound > carboxylic ester > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > (1r,4s,4's,5's,6r,6's,8r,10e,13r,14e,16z,20r,21r,24s)-4',21,24-trihydroxy-5',11,13,22-tetramethyl-6'-[(e)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,18-dione
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic oxo compound > carbonyl compound > carboxylic ester > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > (1r,4s,4's,5's,6r,6's,8r,10e,13r,14e,16z,20r,21r,24s)-4',21,24-trihydroxy-5',11,13,22-tetramethyl-6'-[(e)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,18-dione
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic oxo compound > carbonyl compound > carboxylic ester > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > (1r,4s,4's,5's,6r,6's,8r,10e,13r,14e,16z,20r,21r,24s)-4',21,24-trihydroxy-5',11,13,22-tetramethyl-6'-[(e)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,18-dione
... > organooxygen compound > ester > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > (1r,4s,4's,5's,6r,6's,8r,10e,13r,14e,16z,20r,21r,24s)-4',21,24-trihydroxy-5',11,13,22-tetramethyl-6'-[(e)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,18-dione
... > organooxygen compound > oxacycle > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > (1r,4s,4's,5's,6r,6's,8r,10e,13r,14e,16z,20r,21r,24s)-4',21,24-trihydroxy-5',11,13,22-tetramethyl-6'-[(e)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,18-dione
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > oxacycle > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > (1r,4s,4's,5's,6r,6's,8r,10e,13r,14e,16z,20r,21r,24s)-4',21,24-trihydroxy-5',11,13,22-tetramethyl-6'-[(e)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,18-dione
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > (1r,4s,4's,5's,6r,6's,8r,10e,13r,14e,16z,20r,21r,24s)-4',21,24-trihydroxy-5',11,13,22-tetramethyl-6'-[(e)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,18-dione
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > (1r,4s,4's,5's,6r,6's,8r,10e,13r,14e,16z,20r,21r,24s)-4',21,24-trihydroxy-5',11,13,22-tetramethyl-6'-[(e)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,18-dione
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > macrocycle > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > (1r,4s,4's,5's,6r,6's,8r,10e,13r,14e,16z,20r,21r,24s)-4',21,24-trihydroxy-5',11,13,22-tetramethyl-6'-[(e)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,18-dione
... > organooxygen compound > oxacycle > cyclic ketal > avermectin analogue > milbemycin > (1r,4s,4's,5's,6r,6's,8r,10e,13r,14e,16z,20r,21r,24s)-4',21,24-trihydroxy-5',11,13,22-tetramethyl-6'-[(e)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,18-dione
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > oxacycle > cyclic ketal > avermectin analogue > milbemycin > (1r,4s,4's,5's,6r,6's,8r,10e,13r,14e,16z,20r,21r,24s)-4',21,24-trihydroxy-5',11,13,22-tetramethyl-6'-[(e)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,18-dione
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > cyclic ketal > avermectin analogue > milbemycin > (1r,4s,4's,5's,6r,6's,8r,10e,13r,14e,16z,20r,21r,24s)-4',21,24-trihydroxy-5',11,13,22-tetramethyl-6'-[(e)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,18-dione
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > cyclic ketal > avermectin analogue > milbemycin > (1r,4s,4's,5's,6r,6's,8r,10e,13r,14e,16z,20r,21r,24s)-4',21,24-trihydroxy-5',11,13,22-tetramethyl-6'-[(e)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,18-dione
... > organooxygen compound > acetal > ketal > cyclic ketal > avermectin analogue > milbemycin > (1r,4s,4's,5's,6r,6's,8r,10e,13r,14e,16z,20r,21r,24s)-4',21,24-trihydroxy-5',11,13,22-tetramethyl-6'-[(e)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,18-dione

اصطلاح مرجح

(1r,4s,4's,5's,6r,6's,8r,10e,13r,14e,16z,20r,21r,24s)-4',21,24-trihydroxy-5',11,13,22-tetramethyl-6'-[(e)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,18-dione  

نوع

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

مفهوم اعم

بار

  • 0

فرمول

  • C36H50O9

اینچی

  • InChI=1S/C36H50O9/c1-19(2)13-23(6)31-24(7)29(37)18-35(45-31)17-26-16-25(44-35)12-11-21(4)14-20(3)9-8-10-27-33(39)43-32-30(38)22(5)15-28(34(40)42-26)36(27,32)41/h8-11,13,15,19-20,24-26,28-32,37-38,41H,12,14,16-18H2,1-7H3/b9-8+,21-11+,23-13+,27-10-/t20-,24-,25+,26-,28-,29-,30+,31+,32+,35-,36+/m0/s1

اینچی‌کی

  • NIWUWXDZYTWVHV-RPFDFAGPSA-N

جرم

  • 626.787

جرم تک‌ایزوتوپی

  • 626.34548

اسمایلٓ

  • O=C1O[C@@H]2C[C@@]3(O[C@H](/C(=C/C(C)C)/C)[C@@H](C)[C@H](C3)O)O[C@@H](C2)CC=C(C[C@H](C=CC=C4[C@]5([C@H]1C=C([C@@H](O)[C@H]5OC4=O)C)O)C)C

زیرمجموعه

  • 2_STAR

مترادف دقیق

  • (1R,4S,4'S,5'S,6R,6'S,8R,10E,13R,14E,16Z,20R,21R,24S)-4',21,24-trihydroxy-5',11,13,22-tetramethyl-6'-[(E)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,18-dione

در زبان های دیگر

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:225793

این مفهوم را بارگیری کن:

RDF/XML TURTLE JSON-LD